Correlation Between Nanjing Putian and Jinhe Biotechnology

Can any of the company-specific risk be diversified away by investing in both Nanjing Putian and Jinhe Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nanjing Putian and Jinhe Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nanjing Putian Telecommunications and Jinhe Biotechnology Co, you can compare the effects of market volatilities on Nanjing Putian and Jinhe Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nanjing Putian with a short position of Jinhe Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nanjing Putian and Jinhe Biotechnology.

Diversification Opportunities for Nanjing Putian and Jinhe Biotechnology

0.31

Correlation Coefficient

Nanjing Putian  Jinhe Biotechnology

Weak diversification

The 3 months correlation between Nanjing and Jinhe is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Nanjing Putian Telecommunicati and Jinhe Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jinhe Biotechnology and Nanjing Putian is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nanjing Putian Telecommunications are associated (or correlated) with Jinhe Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jinhe Biotechnology has no effect on the direction of Nanjing Putian i.e., Nanjing Putian and Jinhe Biotechnology go up and down completely randomly.

Pair Corralation between Nanjing Putian and Jinhe Biotechnology

Assuming the 90 days trading horizon Nanjing Putian Telecommunications is expected to under-perform the Jinhe Biotechnology. In addition to that, Nanjing Putian is 1.38 times more volatile than Jinhe Biotechnology Co. It trades about -0.04 of its total potential returns per unit of risk. Jinhe Biotechnology Co is currently generating about 0.03 per unit of volatility. If you would invest  441.00  in Jinhe Biotechnology Co on December 25, 2024 and sell it today you would earn a total of  12.00  from holding Jinhe Biotechnology Co or generate 2.72% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Nanjing Putian Telecommunicati  vs.  Jinhe Biotechnology Co

Nanjing Putian Telec

Risk-Adjusted Performance

Very Weak

Over the last 90 days Nanjing Putian Telecommunications has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Jinhe Biotechnology

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Jinhe Biotechnology Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Jinhe Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Nanjing Putian and Jinhe Biotechnology

The main advantage of trading using opposite Nanjing Putian and Jinhe Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nanjing Putian position performs unexpectedly, Jinhe Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jinhe Biotechnology will offset losses from the drop in Jinhe Biotechnology's long position.

The idea behind Nanjing Putian Telecommunications and Jinhe Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.